ArticleClinical oral investigations2025
Drug interaction between non-steroidal anti-inflammatory drugs and warfarin: a cross-sectional study.
Article in Clinical oral investigations, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Descriptive Analysis of Potential Warfarin-NSAID Interactions in Dental Prescribing in Minas Gerais, Brazil, 2011-2021.Healthcare (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectiveThis study aimed to investigate the frequency, and municipal and individual demographic factors, such as sex and age, associated with potential drug-drug interaction (PDDI) between warfarin and non-steroidal anti-inflammatory drugs (NSAIDs) prescribed by dentists in the state of Minas Gerais (MG), Southeast Brazil. MATERIALS AND
methodsA secondary data analysis of a cross-sectional study was conducted using data from the Integrated Pharmaceutical Care Management System (Sigaf) in MG, Brazil, from January to December 2021. IBM SPSS, version 26.0, and Hierarchical Linear and Nonlinear Modelling, version 7.0, were used for data analysis. Poisson Regression was used to estimate the prevalence ratio of potential drug interactions between individual variables.
resultsData were collected and analyzed from individuals residing in 678 out of 853 municipalities in MG (79.5%). In 2021, 14,474 individuals received warfarin and, among those, 122 received a dental prescription for NSAID. The PDDI occurred in 60 patients. In the multivariate Poisson regression model, increasing age was significantly associated with a lower prevalence of PDDI (p < 0.001).
conclusionsThe frequency of PDDI among warfarin users was low in 2021. However, among those who received warfarin and dental prescriptions for NSAIDs, the occurrence of PDDI was significant. Furthermore, patient age was found to be an influential factor in PDDI. CLINICAL RELEVANCE: These findings guide dental prescribers in managing drug interactions by either avoiding the combination or monitoring for early detection when its administration is necessary, impacting the patient’s oral and general health quality.
Indexed as
Identifiers
41339956What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.